CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 49 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-01 | Lu Lucy Director | Grant or award | +49,383 | 61,273 | ||
| 2024-01-01 | Lu Lucy Director | Grant or award | +3,333 | 11,890 | ||
| 2023-02-10 | Lu Lucy Director | Purchase | +11,976 | $0.84 | $10K | 133,379 |
| 2023-01-01 | Lu Lucy Director | Grant or award | +50,000 | 121,403 | ||
| 2022-12-16 | Lu Lucy Director | Grant or award | +30,000 | 71,403 | ||
| 2014-12-01 | Lu Lucy Chief Financial Officer | Purchase | +5,000 | $1.45 | $7K | 35,631 |
| 2014-06-02 | Lu Lucy Chief Financial Officer | Purchase | +5,000 | $1.37 | $7K | 30,631 |
| 2013-12-04 | Lu Lucy Chief Financial Officer | Purchase | +1,107 | $1.39 | $2K | 25,631 |
| 2013-07-17 | Lu Lucy Chief Financial Officer | Purchase | +4,545 | $7.90 | $36K | 19,524 |
Page 1 of 1 · 9 trades